Circulating ghrelin in thyroid dysfunction is related to insulin resistance and not to hunger, food intake or anthropometric changes

European Journal of Endocrinology

Volumn 153, Issue 1, 2005, Pages 73-79

  Giménez Palop, Olga ^c   Giménez Pérez, Gabriel ^c   Mauricio, Dídac ^c   Berlanga, Eugenio ^a   Potau, Neus ^b   Vilardell, Carme ^c   Arroyo, Jaume ^c   González Clemente, José Miguel ^c   Caixàs, Assumpta ^c  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL MATERNO INFANTIL VALL D HEBRON   (Spain)

^c PARC TAULÍ HOSPITAL UNIVERSITARI   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; INSULIN;

ADULT; ANTHROPOMETRY; APPETITE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; ENERGY BALANCE; FEMALE; FOOD INTAKE; HUMAN; HUNGER; HYPERTHYROIDISM; HYPOTHYROIDISM; INSULIN RESISTANCE; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; THYROID DISEASE;

ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; EATING; ENERGY METABOLISM; FEMALE; HOMEOSTASIS; HUMANS; HUNGER; HYPERTHYROIDISM; HYPOTHYROIDISM; INSULIN RESISTANCE; MALE; MIDDLE AGED; PEPTIDE HORMONES; PREDICTIVE VALUE OF TESTS; THYROID GLAND;

EID: 22744448692     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.01934     Document Type: Article

References (44)

1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H & Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999 402 656-660.
2. Tschöp M, Smiley DL & Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000 407 908-913.
3. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K & Matsukura S. A role for ghrelin in the central regulation of feeding. Nature 2001 409 194-198.
4. Arvat E, Di Vito L, Broglio F, Papotti M, Muccioli G, Díeguez C, Casanueva FF, Deghenghi R, Camanni F & Ghigo E. Preliminary evidence that ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. Journal of Endocrinological Investigations 2000 23 493-495.
5. Wren AM, Small CJ, Abbott CR, Dhillo WS, Seal le IJ, Cohen MA, Batterham RL, Taheri RL, Stanley SA, Ghatei MA & Bloom SR. Ghrelin causes hyperphagia and obesity in rats. Diabetes 2001 50 2540-2547.
6. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA & Bloom SR. Ghrelin enhances appetite and increases food intake in humans. Journal of Clinical Endocrinology and Metabolism 2001 86 5992-5996.
7. Cummings D, Purnell J, Frayo R, Schmidova K, Wisse B & Weigle D. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001 50 1-6.
8. Sainsbury A, Cooney G & Herzog H. Hypothalamic regulation of energy homeostasis. Best Practice & Research Clinical Endocrinology and Metabolism 2002 16 623-637.
9. Shintani M, Ogawa Y, Ebihara K, Aizawa-Abe M, Miyanagu F, Takaya K, Hayashi T, Inoue G, Hosoda K, Kojima M, Kangawa K & Nakao K. Ghrelin an endogenous growth hormone secretagogue is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 2001 50 227-232.
10. Tschöp M, Wawarta R, Riepl R, Friedrich S, Bidlingmaier M, Landgraf R & Folwaczny C. Post-prandial decrease of circulating human ghrelin levels. Journal of Endocrinological Investigations 2001 24 RC19-RC21.
11. Tschöp M, Weyer C, Tataranni A, Devanarayan V, Ravussin E & Heiman M. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001 50 707-709.
12. Caixàs A, Bashore C, Nash W, Pi-Sunyer FX & Laferrère B. Insulin, unlike food intake, does not suppress ghrelin in human subjects. Journal of Clinical Endocrinology and Metabolism 2002 87 1902-1906.
13. Nedvídková J, Krykorková I, Barták V, Papezová H, Gold P, Alesci S & Pacak K. Loss of meal-induced decrease in plasma ghrelin levels in patients with anorexia nervosa. Journal of Clinical Endocrinology and Metabolism 2003 88 1678-1682.
14. Flanagan DE, Evans ML, Monsod TP, Rife F, Heptulla RA, Tamborlane WV & Sherwin RS. The influence of insulin on circulating ghrelin. American Journal of Physiology-Endocrinology and Metabolism 2003 284 E313-E316.
15. Saad MF, Bernaba B, Hwu C, Jinagouda S, Fahmi S, Kosogov E & Boyadjian R. Insulin regulates plasma ghrelin concentration. Journal of Clinical Endocrinology and Metabolism 2002 87 3997-4000.
16. Purnell JQ, Weigle DS, Breen P & Cummings DE. Ghrelin levels correlate with insulin levels, insulin resistance, and high-density lipoprotein cholesterol, but not with gender, menopausal status, or cortisol levels in humans. Journal of Clinical Endocrinology and Metabolism 2003 88 5747-5752.
17. McLaughlin T, Abbasi F, Lamendola C, Frayo RS & Cummings DE. Plasma ghrelin concentrations are decreased in insulin-resistance obese adults relative to equally obese insulin-sensitive controls. Journal of Clinical Endocrinology and Metabolism 2004 89 1630-1635.
18. Ikezaki A, Hosoda H, Ito K, Iwama S, Miura N, Matsuoka H, Kondo C, Kojima M, Kangawa K & Sugihara S. Fasting plasma ghrelin levels are negatively correlated with insulin resistance and PAI-1, but not with leptin, in obese children and adolescents. Diabetes 2002 51 3408-3411.
19. Kreines K, Jett M & Knowles HC. Observation in hyperthyroidism of abnormal glucose tolerance and other traits related to diabetes mellitus. Diabetes 1965 14 740-744.
20. Dimitriadis G, Baker B, Marsh H, Mandarino L, Rizza R, Bergman R, Haymond M & Gerich J. Effect of thyroid hormone excess on action, secretion, and metabolism of insulin in humans. American Journal of Physiology 1985 248 E593-E601.
21. O'Meara NM, Blackman JD, Sturis J & Polonsky KS. Alterations in the kinetics of C-peptide and insulin secretion in hyperthyroidism. Journal of Clinical Endocrinology and Metabolism 1993 76 79-84.
22. Loeb JN. Metabolic changes in thyrotoxicosis. In Werner's the thyroid, edn 7, ch 73, pp 858-863. Eds SH Ingbar & LE Braveman. Philadelphia: Lippincott, 1996.
23. Riis ALD, Hansen TK, Moller N, Weeke J & Jorgensen JOL. Hyperthyroidism is assocated with suppressed circulating ghrelin levels. Journal of Clinical Endocrinology and Metabolism 2003 88 853-857.
24. Cummings DE, Frayo RS, Marmonier C, Aubert R & Chapelot D. Plasma ghrelin levels and hunger scores among humans initiating meals voluntarily in the absence of time-and food-related cues. American Journal of Physiology - Endocrinology and Metabolism 2004 287 E297-E304.
25. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419.
26. Loeb JN. Metabolic changes in thyrotoxicosis. In Werner's the thyroid, edn 7, ch 49, pp 687-693. Eds SH Ingbar & LE Braveman. Philadelphia: Lippincott, 1996.
27. Otto B, Cuntz U, Fruehauf E, Wawarta R, Folwaczny C, Riepl RL, Heiman M, Lehnert P, Fichter M & Tschöp M. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. European Journal of Endocrinology 2001 145 R5-R9.
28. Caminos JE, Seoane LM, Tovar SA, Casabueva FF & Dieguez C. Influence of thyroid status and growth hormone deficiency on ghrelin. European Journal of Endocrinology 2002 147 159-163.
29. Schaller G, Schmidt A, Pleiner J, Woloszczuck W, Woltz M & Luger A. Plasma ghrelin concentrations are not regulated by glucose or insulin: a double-blind, placebo-controlled crossover clamp study. Diabetes 2003 52 16-20.
30. Schofl C, Horn R, Schill T, Schlosser HW, Muller MJ & Brabant G. Circulating ghrelin levels in patients with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2002 87 4607-4610.
31. Haqq AM, Farooqi S, O'Rahilly S, Stadler DD, Rosenfield RG, Pratt KL, La Franchi SH & Purnell JQ. Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome. Journal of Clinical Endocrinology and Metabolism 2003 88 174-178.
32. Loeb JN. Catecholamines and the sympathoadrenal system in thyrotoxicosis. In Werner's the thyroid, edn 7, ch 46, pp 661-670. Eds SH Ingbar & LE Braveman. Philadelphia: Lippincott, 1996.
33. Loeb JN. The pituitary in thyrotoxicosis. In Werner's the thyroid, edn 7, ch 44, pp 653-655. Eds SH Ingbar & LE Braveman. Philadelphia: Lippincott, 1996.
34. Taylor AL, Finster JL & Mintz DH. Metabolic clearance and production rates of human growth hormone. Journal of Clinical Investigation 1969 48 2349-2358.
35. Iranmanesh A, Lizarralde G, Johnson ML & Veldhuis JD. Nature of altered growth hormone secretion in hyperthyroidism. Journal of Clinical Endocrinology and Metabolism 1991 72 108-115.
36. Cooper DS, Ridgway EC, Kliman B, Kjellberg RN & Maloof F. Metabolic clearance and production rates of prolactin in man. Journal of Clinical Investigation 1979 64 1669-1680.
37. Snyder PJ, Jacobs LS, Utiger RD & Daughaday WH. Thyroid hormone inhibition of the prolactin response to thyrotropin-realising hormone. Journal of Clinical Investigation 1973 52 2324-2329.
38. Ciccarelli E, Zini M, Grottoli S, Razzore P, Portioli I & Valcavi R. Impaired prolactin response to arginine in patients with hyperthyroidism. Clinical Endocrinology 1994 41 371-374.
39. Cummings D, Weigle D, Frayo R, Breen P, Ma M, Dellinger E & Purnell J. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. New England Journal of Medicine 2002 346 1623-1632.
40. Hansen TK, Dall R, Hosoda H, Kojima M, Kangawa K, Christiansen JS & Jorgensen JO. Weight loss increases circulating levels of ghrelin in human obesity. Clinical Endocrinology 2002 56 203-206.
41. Pijl H, de Meijer P, Langius J, Coenegracht C, Berk A, Shaw P, Boom H, Schoemaker R, Cohen A, Burggraaf J & Meinders A. Food choice in hyperthyroidism: potential influence of the autonomic nervous system and brain serotonin precursor availability. Journal of Clinical Endocrinology and Metabolism 2001 86 5848-5853.
42. Ishii S, Kanegai J, Tamura H, Shimizu T, Sugihara H & Oikawa S. Hypothalamic neuropeptide Y/Y1 receptor pathway activated by a reduction in circulating leptin, but not by an increase in circulating ghrelin, contributes to hyperphagia associated with triiodothyronine-induced thyrotoxicosis. Neuroendocrinology 2003 78 321-330.
43. Patterson M, Murphy KG, le Roux CW, Ghatei MA & Bloom SR. Characterisation of ghrelin-like immunoreactivity in human plasma. Journal of Clinical Endocrinology and Metabolism 2005 90 2205-2211.
44. Beaumont NJ, Skinner VO, Tan TM, Ramesh BS, Byme DJ, MacColl GS, Keen JN, Bouloux PM, Mikhailidis DP, Bruckdorfer KR, Vanderpump MP & Srai KS. Ghrelin can bind to a species of high density lipoprotein associated with paraoxonase. Journal of Biological Chemistry 2003 278 8877-8880.